Do cancer patients overestimate drug benefits? a trial puts communication to the test.
NCT ID NCT07731425
First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time
Summary
This study asks whether adding overall survival data to standard progression-free survival information helps current or former cancer patients more accurately judge a new drug's survival benefit. Around 3,000 U.S. adults with a past or present cancer diagnosis will read about a hypothetical cancer drug and answer questions about its effectiveness. The goal is to see if clearer communication reduces unrealistic expectations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could improve how doctors communicate drug benefits, helping patients make more informed treatment decisions.
- What could go wrong
- This is a survey-based study, not a treatment trial. It measures expectations, not actual outcomes, and results may not change real-world practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harvard Medical School and Harvard Pilgrim Health Care Institute
Boston, Massachusetts, 02215, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- A simple screening program could transform cancer aftercare
- Can simple positive activities boost Well-Being in cancer care?